172 related articles for article (PubMed ID: 33568562)
1. Eyelash trichomegaly induced by erlotinib for metastatic lung cancer.
Chan JYY; Kwok TYT; Yuen HKL
Hong Kong Med J; 2021 Feb; 27(1):60.e1-60.e3. PubMed ID: 33568562
[No Abstract] [Full Text] [Related]
2. Ocular side effects and trichomegaly of eyelashes induced by erlotinib: a case report and review of the literature.
Celik T; Kosker M
Cont Lens Anterior Eye; 2015 Feb; 38(1):59-60. PubMed ID: 25249292
[TBL] [Abstract][Full Text] [Related]
3. Trichomegaly of the eyelashes following treatment with cetuximab.
Vaccaro M; Pollicino A; Barbuzza O; Guarneri B
Clin Exp Dermatol; 2009 Apr; 34(3):402-3. PubMed ID: 19120397
[No Abstract] [Full Text] [Related]
4. Trichomegaly of the eyelashes during therapy with epidermal growth factor receptor inhibitors: report of 3 cases.
Fabbrocini G; Panariello L; Cacciapuoti S; Bianca D; Ayala F
Dermatitis; 2012; 23(5):237-8. PubMed ID: 23010833
[TBL] [Abstract][Full Text] [Related]
5. Trichomegaly of the eyelashes following treatment with cetuximab.
Bouché O; Brixi-Benmansour H; Bertin A; Perceau G; Lagarde S
Ann Oncol; 2005 Oct; 16(10):1711-2. PubMed ID: 15972283
[No Abstract] [Full Text] [Related]
6. Erlotinib-associated trichomegaly.
Lane K; Goldstein SM
Ophthalmic Plast Reconstr Surg; 2007; 23(1):65-6. PubMed ID: 17237698
[TBL] [Abstract][Full Text] [Related]
7. Eyelid and eyelash changes due to prostaglandin analog therapy in unilateral treatment cases.
Yoshino T; Fukuchi T; Togano T; Seki M; Ikegaki H; Abe H
Jpn J Ophthalmol; 2013 Mar; 57(2):172-8. PubMed ID: 23208023
[TBL] [Abstract][Full Text] [Related]
8. Cetuximab-associated elongation of the eyelashes: case report and review of eyelash trichomegaly secondary to epidermal growth factor receptor inhibitors.
Cohen PR; Escudier SM; Kurzrock R
Am J Clin Dermatol; 2011 Feb; 12(1):63-7. PubMed ID: 20726623
[TBL] [Abstract][Full Text] [Related]
9. [Trichomegaly due to cetuximab].
Bagazgoitia L; Aboín S; Beà S; Muñoz E
Med Clin (Barc); 2009 Sep; 133(8):323. PubMed ID: 19540538
[No Abstract] [Full Text] [Related]
10. Eyelash trichomegaly associated with systemic tacrolimus.
Ward KM; Barnett C; Fox LP; Grossman ME
Arch Dermatol; 2006 Feb; 142(2):248. PubMed ID: 16490862
[No Abstract] [Full Text] [Related]
11. Trichomegaly secondary to erlotinib.
Desai RU; Rachakonda LP; Saffra NA
Can J Ophthalmol; 2009 Dec; 44(6):e65. PubMed ID: 20052001
[No Abstract] [Full Text] [Related]
12. Epidermal Growth Factor Receptor Inhibitor Induced Trichomegaly and Poliosis.
Goyal S; Uwaydat SH
Ophthalmology; 2018 Feb; 125(2):294. PubMed ID: 29389408
[No Abstract] [Full Text] [Related]
13. Severe Onycholysis and Eyelash Trichomegaly Following Use of New Selective Pan-FGFR Inhibitors.
Bétrian S; Gomez-Roca C; Vigarios E; Delord JP; Sibaud V
JAMA Dermatol; 2017 Jul; 153(7):723-725. PubMed ID: 28538953
[No Abstract] [Full Text] [Related]
14. Triad of trichomegaly, alopecia and male-pattern hair growth during treatment with erlotinib in non-small-cell lung cancer.
Forde P; Murphy C; O'Sullivan C; Carney D
Ir J Med Sci; 2011 Mar; 180(1):283-4. PubMed ID: 20108129
[TBL] [Abstract][Full Text] [Related]
15. Trichomegaly induced by erlotinib.
Papadopoulos R; Chasapi V; Bachariou A
Orbit; 2008; 27(4):329-30. PubMed ID: 18716976
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal thumbnail fissures due to erlotinib therapy for lung cancer.
Dasanu CA; Alvarez-Argote J; Lippman SM; Plaxe SC
J Oncol Pharm Pract; 2018 Apr; 24(3):229-231. PubMed ID: 28436313
[TBL] [Abstract][Full Text] [Related]
17. Erlotinib-induced reactive perforating collagenosis in a case of lung adenocarcinoma.
Jiang X; Song TT; Hao F
Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):548-551. PubMed ID: 34219432
[No Abstract] [Full Text] [Related]
18. Scanning electron microscopy of panitumumab-induced eyelash and hair alterations - Pili canaliculi.
Sarzi Sartori D; Larangeira de Almeida A; Santana Pereira de Oliveira G; de Almeida HL
An Bras Dermatol; 2022; 97(2):240-242. PubMed ID: 35042642
[TBL] [Abstract][Full Text] [Related]
19. [Panitumumab-induced trichomegaly].
Vañó-Galván S; Longo F; Grillo E; Jaén P
Med Clin (Barc); 2013 Apr; 140(8):e15. PubMed ID: 23490492
[No Abstract] [Full Text] [Related]
20. Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis.
Vij A; Bergfeld WF
Clin Dermatol; 2015; 33(2):217-26. PubMed ID: 25704941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
